{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27255563", "DateCompleted": {"Year": "2018", "Month": "01", "Day": "05"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "06", "Day": "03"}], "ELocationID": ["10.1038/cgt.2016.24"], "Language": ["eng"], "Journal": {"ISSN": "1476-5500", "JournalIssue": {"Volume": "23", "Issue": "7", "PubDate": {"Year": "2016", "Month": "Jul"}}, "Title": "Cancer gene therapy", "ISOAbbreviation": "Cancer Gene Ther"}, "ArticleTitle": "Physalis alkekengi and Alhagi maurorum ameliorate the side effect of cisplatin-induced nephrotoxicity.", "Pagination": {"StartPage": "235", "EndPage": "240", "MedlinePgn": "235-40"}, "Abstract": {"AbstractText": ["Cisplatin is frequently being used for the treatment of different tumors, although the application of this agent is associated with nephrotoxicity. Here, we explored the antioxidant and anti-inflammatory activities of Physalis alkekengi and Alhagi maurorum; 400\u2009mg\u2009kg(-1) per day P. alkekengi and 100\u2009mg\u2009kg(-1) per day A. maurorum were administered in rats, orally for 10 days after a single dose of 7 mg kg(-1) intraperitoneal cisplatin. The concentrations of creatinine, urea-nitrogen, and relative and absolute excretion of sodium/potassium were evaluated before/after therapy. Levels of malondialdehyde (MDA) and ferric-reducing antioxidant power (FRAP) were measured to assess the oxidative stress induced by cisplatin. Moreover, tissues sections were used for histological analyses and evaluation of the degree of tissue damage. Cisplatin increased serum levels of creatinine and urea-nitrogen, relative/absolute excretion of sodium/potassium, and MDA, whereas decreased FRAP level. Interestingly, P. alkekengi or A. maurorum were able to reduce the level of the renal function markers as well as the levels of sodium/potassium. This effect was more pronounced by P. alkekengi. Moreover, cisplatin induced pathological damage in kidney, whereas treatment with these agents improved this condition. Our findings demonstrate the potential therapeutic impact of P. alkekengi and A. maurorum for improving cisplatin-induced nephrotoxicity, supporting further investigations on the novel potential clinical application of these agents for patients being treated with cisplatin to ameliorate cisplatin-induced nephrotoxicity."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Arak University of Medical Sciences, Arak, Iran."}], "LastName": "Changizi-Ashtiyani", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Arak University of Medical Sciences, Arak, Iran."}], "LastName": "Alizadeh", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran."}], "LastName": "Najafi", "ForeName": "H", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Histology, Arak University of Medical Sciences, Arak, Iran."}], "LastName": "Babaei", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Arak University of Medical Sciences, Arak, Iran."}], "LastName": "Khazaei", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Arak University of Medical Sciences, Arak, Iran."}], "LastName": "Jafari", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Plants, University of Arak, Arak, Iran."}], "LastName": "Hossaini", "ForeName": "N", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Medicine Group, Department of Modern Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Avan", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Nephrology, School of Medicine, Saint Louis University, Saint Louis, MO, USA."}], "LastName": "Bastani", "ForeName": "B", "Initials": "B"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Cancer Gene Ther", "NlmUniqueID": "9432230", "ISSNLinking": "0929-1903"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "Q20Q21Q62J", "NameOfSubstance": "Cisplatin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["toxicity"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["toxicity"], "DescriptorName": "Cisplatin"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": ["chemistry"], "DescriptorName": "Fabaceae"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Kidney Tubules, Proximal"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["chemistry"], "DescriptorName": "Physalis"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Renal Insufficiency"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Clin Cancer Res. 2008 Jun 15;14(12):3875-80", "ArticleIdList": ["18559608"]}, {"Citation": "Pharmacol Toxicol. 2000 May;86(5):234-41", "ArticleIdList": ["10862506"]}, {"Citation": "Mediators Inflamm. 2004 Dec;13(5-6):307-12", "ArticleIdList": ["15770045"]}, {"Citation": "Pharmacol Res. 2001 Oct;44(4):317-20", "ArticleIdList": ["11592867"]}, {"Citation": "Anticancer Res. 1992 May-Jun;12(3):885-98", "ArticleIdList": ["1535771"]}, {"Citation": "Phytother Res. 2015 Jan;29(1):1-13", "ArticleIdList": ["25256791"]}, {"Citation": "Am J Pathol. 2005 Dec;167(6):1477-84", "ArticleIdList": ["16314463"]}, {"Citation": "J Am Soc Nephrol. 2001 Dec;12(12):2683-90", "ArticleIdList": ["11729237"]}, {"Citation": "Mediators Inflamm. 2004 Feb;13(1):13-9", "ArticleIdList": ["15203559"]}, {"Citation": "Food Chem Toxicol. 2010 Oct;48(10):2785-90", "ArticleIdList": ["20633591"]}, {"Citation": "Pediatr Hematol Oncol. 2005 Jul-Aug;22(5):441-5", "ArticleIdList": ["16020136"]}, {"Citation": "J Lab Clin Med. 2003 Sep;142(3):178-86", "ArticleIdList": ["14532906"]}, {"Citation": "Toxins (Basel). 2010 Nov;2(11):2490-518", "ArticleIdList": ["22069563"]}, {"Citation": "Toxicology. 2004 Feb 15;195(2-3):221-30", "ArticleIdList": ["14751677"]}, {"Citation": "J Appl Toxicol. 2004 Jan-Feb;24(1):27-35", "ArticleIdList": ["14745844"]}, {"Citation": "Steroids. 2012 Apr;77(5):441-7", "ArticleIdList": ["22197662"]}, {"Citation": "Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14298-302", "ArticleIdList": ["12370430"]}, {"Citation": "J Asian Nat Prod Res. 2010 Feb;12 (2):138-43", "ArticleIdList": ["20390757"]}, {"Citation": "J Ethnopharmacol. 2011 Apr 26;135(1):95-101", "ArticleIdList": ["21354293"]}, {"Citation": "Semin Nephrol. 2003 Sep;23(5):460-4", "ArticleIdList": ["13680535"]}, {"Citation": "Methods Enzymol. 1999;299:15-27", "ArticleIdList": ["9916193"]}, {"Citation": "Chemotherapy. 2002 Mar;48(1):42-8", "ArticleIdList": ["11901256"]}, {"Citation": "Nat Prod Res. 2012;26(2):173-6", "ArticleIdList": ["21834635"]}, {"Citation": "J Clin Invest. 2002 Sep;110(6):835-42", "ArticleIdList": ["12235115"]}, {"Citation": "Kidney Int. 2004 Jul;66(1):196-202", "ArticleIdList": ["15200426"]}, {"Citation": "Pharmacol Res. 2003 Jun;47(6):517-22", "ArticleIdList": ["12742005"]}, {"Citation": "Cancer Chemother Pharmacol. 2007 Mar;59(4):455-60", "ArticleIdList": ["16855841"]}, {"Citation": "Biochem Biophys Res Commun. 1989 Mar 31;159(3):1121-7", "ArticleIdList": ["2930553"]}, {"Citation": "Cancer Chemother Pharmacol. 1989;25(1):1-9", "ArticleIdList": ["2686850"]}, {"Citation": "Anal Biochem. 1979 Jun;95(2):351-8", "ArticleIdList": ["36810"]}, {"Citation": "J Agric Food Chem. 2007 Dec 12;55(25):10150-5", "ArticleIdList": ["18001039"]}, {"Citation": "Iran J Kidney Dis. 2014 Jul;8(4):292-8", "ArticleIdList": ["25001135"]}, {"Citation": "Invest New Drugs. 2000 Aug;18(3):281-9", "ArticleIdList": ["10958599"]}, {"Citation": "Biometals. 1996 Apr;9(2):139-42", "ArticleIdList": ["8744896"]}, {"Citation": "Iran J Kidney Dis. 2013 Jul;7(4):290-8", "ArticleIdList": ["23880806"]}, {"Citation": "Biomed Res Int. 2014;2014:589168", "ArticleIdList": ["24511537"]}, {"Citation": "Expert Opin Pharmacother. 2003 Jun;4(6):889-901", "ArticleIdList": ["12783586"]}, {"Citation": "Pharmacol Res. 2003 Feb;47(2):149-56", "ArticleIdList": ["12543063"]}, {"Citation": "Clin Hemorheol Microcirc. 2008;39(1-4):93-8", "ArticleIdList": ["18503115"]}, {"Citation": "Am J Kidney Dis. 1993 Apr;21(4):374-7", "ArticleIdList": ["8465815"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "4", "Day": "2"}, {"Year": "2016", "Month": "5", "Day": "9"}, {"Year": "2016", "Month": "6", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "6", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "1", "Day": "6", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27255563", "10.1038/cgt.2016.24", "cgt201624"]}}], "PubmedBookArticle": []}